Anal cancer, especially squamous cell carcinoma (SCC) variety, is evolving with rising incidence globally. This is due to the increasing adoption of risky life styles and social habits even in populations with rare occurrences previously. This case report aims to expose risk factors exhibited by a patient recently managed for anal cancer in our facility before his demise. Early exposure to bisexual orientation, receptive anal intercourse and multiple sexual partners, are notable high risk factors for the development of anal SCC. The permissive role of smoking, illicit drug and alcohol use enhances the disease occurrence. Acquisition of human immune-deficiency virus (HIV) sero-positive status further reduces the body's immune competence and enhances early age of onset as well as accelerates development of anal SCC. Proper history exploring the risk factors, physical/anorectal examination and histological analysis, are vital for proper diagnosis and staging which guides appropriate treatment with chemo-radiation as mainstay.
Introduction
Anal cancer is a rare disease globally and much rarer in our setting even when symptomatic, though rising in incidence among developed countries [1] [2] .
Most cases are seen in the elderly women. Squamous cell carcinoma (SCC) is the predominant type and constitutes up to 80 percent of cases of anal cancer [3] .
Human Papilloma Virus (HPV) sero-types 16 and 18 infection, has been impli-cated as causative agents in about 84% of cases [3] . Life styles/social habits such as having multiple gay partners, receptive anal intercourse as well as smoking cigarettes, doing drugs and alcohol abuse, contribute significantly to increase the risk of developing anal SCC [1] [2] [3] . The acquisition of human immunodeficiency virus HIV) seropositivity is an independent risk factor [3] which increases the risk exponentially. Asuquo et al. [4] , described SCC irrespective of site, as a slow-growing malignancy that hardly threatens life.
Although gay behaviour is culturally and legally prohibited in our country, an increasing number of people mostly youths continue to engage in it and other risky life styles clandestinely. An appropriate prevention strategy is needed to stem the rising cases of risky sexual behaviour/life style which may lead to higher incidence of anal cancer in the near future through health education.
Case Report
UMI is a single, 34 year old male Caterer, working in Lagos. He was admitted through Accident/Emergency in July 2016 and later referred to our surgical team on account of anal mass and bleeding per rectum of 6 months duration in addition to general lassitude.
Patient was apparently well until about seven months prior to presentation when he noticed a small, painless, itchy anal mass. The mass gradually increased in size over a few months, became ulcerated and bled intermittently prior to presentation. It was later associated with insidious onset of pain, which was sharp and persistent, non-radiating, aggravated by strenuous activities and defecation. There was no relieving factor but he adopted the prone position as the most comfortable position for most of the day.
The passage of intermittent bloody stool started 2 weeks after noticing the anal mass. The blood occasionally smeared the stool and sometimes came as frank bleeding. It did not contain clots and was not associated with dizziness initially. His stool was soft, formed and regular once daily. Later, he noticed purulent anal discharge which preceded the passage of mal-odorous stool and progressed to passage of dark stool mixed with pus. There was associated loss of appetite and feeling unwell but no nausea nor vomiting. He had no abdominal pain or change in bowel habit. There was associated marked weight loss and progressive body weakness. He presented at a private hospital in Lagos where he was diagnosed of RVD and placed on ARV (Lamivudine, Abacavir, Efavirenz) in addition to receiving one unit of whole blood transfusion. His symptoms did not improve after one month of treatment, thus he relocated to his Calabar home town. He got progressively worse with extreme weakness and presented at the Accident/Emergency unit of a tertiary health facility for further management after defaulting on his ARV drug therapy for six months without explanation.
He had no significant past medical history. He takes alcohol occasionally denies use of tobacco or hard drugs in any form.
He was the 3 rd child among 6 siblings in a polygamous setting. He was single Physical examination showed a chronically ill-looking, cachexic, febrile young man in painful distress. He was conscious, alert and well-oriented. He had severe pallor but was anicteric and dehydrated. Oral thrush was present with bilateral inguinal lymph node enlargement and bilateral pitting pedal oedema. His blood pressure, pulse rate and respiratory rates were within normal range. He had no sensory neurological deficit but power in the lower limbs was grade three. His chest was clinically clear. He had no obvious deformity. The abdomen was not remarkable.
Rectal examination revealed perianal warts with huge ulcerated anal mass close to the midline posteriorly (see Figure 1 ) with associated multiple anal fistulae draining pus and blood. The anal sphincter was lax and adjacent rectal wall had multiple tender indurated nodules extending from the anterior to the posterior aspect and some granular areas, which provoked bleeding on palpation. The prostate gland was clinically normal and the examining fingerstall was stained with fresh blood. A wedge biopsy of the ulcerated anal lesions showed a well differentiated Squamous cell carcinoma (SCC) extending to the underlying dermis and areas of dysplastic keratinocytes (see Figure 2) .
He was re-commenced on anti-retroviral treatment using Lamivudine/Abacavir/Efavirenz combination plus antibiotics, oral antifungal, haematinics, daily 
Discussion
Anal Annual anal PAP smear is recommended in those at risk as is done to screen for cervical cancer in women [8] [9] . The histologic examination of a biopsy specimen is very essential to differentiate anal SCC from other similarly presenting anal lesions like Melanoma, Adenocarcinoma and Basal Cell Carcinoma. The treatment of anal cancer is not straight forward. Histologic classification and staging are important. Anal SCC spreads mostly by the lymphatic route. Patient should be fit or optimized for whatever treatment modality in use. The treatment of the various grades of precancerous lesions holds the key to preventing advancement while screening and vaccination of those with risky behaviour has been advocated. This appears feasible since the same approach has reduced the incidence of cervical cancer in women and both anal and cervical cancer share the same aetiological agent in HPV types 16 and 18. Patients with RVD in addition to anal cancer have a peculiar challenge. They usually succumb to Retro-Viral Disease (RVD) rather than anal cancer, from effects of HIV and very low CD4 + count < 200 [7] [9]. This further suggests that HIV positive patients with anal cancer, cannot withstand the toxicity of chemotherapy and must have intensive anti-retroviral therapy initially, before commencing cancer chemotherapy. The treatment of invasive anal SCC is based on Radiotherapy and Chemotherapy using Mitomycin C (MMC) and 5-Fluoro-Uracil. In addition, combination with HAART will greatly increase toxicity as both are immunosuppressive. A CD4 + count of 200 or more is used to determine HIV+ patients in whom chemotherapy should be tried [1] [7] [8] [9] . In addition, several workers have noted the difficulty and severity of adverse reactions to cytotoxic therapy in those with HIV/AIDS. They opine that intensive anti-retroviral therapy must be instituted first and continued until CD4 + count rises above 200 before exhibiting cytotoxic chemotherapy as planned in our index patient before his demise.
In cases of persistent biopsy positive anal cancer after chemo-radiation, with no metastatic lesions, it has been suggested that an Abdomino-Perineal resection with terminal colostomy should be considered [1] [6] . Current studies on treatment of anal SCC is focusing on molecular targeted therapy as some genes like EGFR, c-Met and VEGFR [1] are over-expressed especially in those who are HIV positive. The goal of therapy in anal SCC, even among HIV positive ones is to eradicate the disease before dissemination and improve the quality of life including avoidance of colostomy.
Preventive measures are equally important but it requires a high index of suspicion to identify those with risky life styles as targets for health education, screening and vaccination by using Gardasil and early treatment of precancerous lesions. Very important risk factors raised in this case need closer attention in the populace with a view to marshalling strategies for curbing or stemming the rising incidence. It also underlies the importance of early detection and prompt treatment before the development of invasive anal SCC. HIV positive patients
